Evidence from bone infection, such as osteomyelitis or prosthetic joint infection (PJI), has suggested another biomarker, along with sCD14ST, able to conjugate inflammatory response and bone loss [60]: SuPAR [soluble urokinase plasminogen activator receptor]. This evidence concerns the gene PLAUR and osteomyelitis.